If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
377.50    2.50 (0.67%)
Bid:
374.50
Ask:
376.50
Spread: 2.00 (0.534%)
Market Cap: £1.93b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Update to Net Asset Value

19 Jun 2014 09:32

RNS Number : 0191K
Caledonia Investments PLC
19 June 2014
 



 

 

 

Caledonia Investments plc

 

Update to Net Asset Value

 

 

Caledonia Investments plc ("Caledonia") provides the following update to its net asset value ("NAV").

 

As previously announced, Caledonia's unaudited diluted NAV per share as at 31 May 2014 was 2624p. Caledonia is today providing an update to this NAV per share in relation to the current market valuation of JD.com, Inc ("JD.com"), one of China's largest online direct sales companies, which recently listed on NASDAQ. JD.com is one of the investments held within the Capital Today China Growth Fund, L.P. ("CTC Fund"), a private equity fund focused on investment in consumer, retail and internet sectors in China and in which Caledonia has a limited partner interest as part of its Funds pool.

 

Since its initial public offering on 22 May 2014, the price of JD.com's American Depository Shares ("ADS") has risen by over 40%, from $19 to $26.52 per ADS as at close of business on 18 June 2014. On a look-through basis, Caledonia owns 5.6m ADS in JD.com via the CTC Fund. At this level of valuation, the potential increase to Caledonia's NAV as at 31 May 2014 would be approximately £46m, some 83p per share, after taking account of fund-related deductions such as carried interest, management fees and withholding tax of 10%. This potential increase does not take account of any changes in values attributable to any of the other investments held by the CTC Fund or within the wider Caledonia portfolio.

 

It should be emphasised that the holding in JD.com is not tradable directly by Caledonia and that the CTC Fund is itself subject to a six month lock-in post the initial public offering (ending 22 November 2014). The overall value of Caledonia's interest in the CTC Fund is also dependent on the value changes of the other investments held within the fund.

 

In line with Caledonia's valuation policy, the valuation of the holding in the CTC Fund will be formally updated within Caledonia's NAV on receipt of the next CTC Fund manager's valuation (which may include any discount assessed as appropriate by the manager). It is expected that this next valuation will be reflected in Caledonia's half year NAV per share announcement as at 30 September 2014.

 

 

Enquiries

 

Caledonia Investments plc

Will Wyatt (Chief Executive)

Stephen King (Finance Director)

Tel: +44 20 7802 8080

 

Tulchan Communications

Peter Hewer

Tel: +44 20 7353 4200

 

19 June 2014

 

END

 

 

The monthly reported NAV per share, together with performance statistics and information on the valuation of principal investments, is available on Caledonia's website at www.caledonia.com. Neither the contents of the company's website nor the contents of any website accessible from hyperlinks on the company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

Further information on JD.com and the CTC Fund may be found on Capital Today China's website at www.capitaltoday.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVQKCDNFBKKDAD
Date   Source Headline
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSChange of Adviser
6th Feb 20257:00 amRNSNet Asset Value(s)
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSPrivate Capital spotlight event
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSNet Asset Value(s)
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
18th Dec 20244:52 pmRNSResult of Meeting
5th Dec 202412:22 pmRNSNet Asset Value(s)
2nd Dec 20247:00 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSCircular and Notice of General Meeting
26th Nov 20247:00 amRNSHalf-year Report
21st Nov 20241:56 pmRNSTransaction in Own Shares
19th Nov 20247:00 amRNSNotice of Half-Year Results
18th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20249:43 amRNSNet Asset Value(s)
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 202412:09 pmRNSHolding(s) in Company
28th Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSNet Asset Value(s)
7th Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 20244:50 pmRNSTotal Voting Rights
30th Sep 20243:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.